It has been reported that different cell types in the tumor niches produce IL-6, and the IL-6/JAK/STAT3 pathway is aberrantly hyperactivated in many cancers, leading to the increased tumor-cell growth and progression, survival, and metastasis. Here, IL6 is linked to neoplasm.